These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10815157)

  • 1. Selective photodynamic effects of the new photosensitizer ATX-S10(Na) on choroidal neovascularization in monkeys.
    Obana A; Gohto Y; Kanai M; Nakajima S; Kaneda K; Miki T
    Arch Ophthalmol; 2000 May; 118(5):650-8. PubMed ID: 10815157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDT to monkey CNV with ATX-S10(Na): inappropriateness of early laser irradiation for selective occlusion.
    Obana A; Gohto Y; Kaneda K; Nakajima S; Miki T
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2639-45. PubMed ID: 11581211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective occlusion of choroidal neovascularization by photodynamic therapy with a water-soluble photosensitizer, ATX-S10.
    Obana A; Gohto Y; Kaneda K; Nakajima S; Takemura T; Miki T
    Lasers Surg Med; 1999; 24(3):209-22. PubMed ID: 10229152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of photodynamic therapy with ATX-S 10 (Na) on experimental choroidal neovascularization].
    Hirose T; Nakajima M; Kyou T; Yuzawa M
    Nippon Ganka Gakkai Zasshi; 2006 Jun; 110(6):445-53. PubMed ID: 16808159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scanning laser system for photodynamic therapy of choroidal neovascularization.
    Obana A; Gohto Y
    Lasers Surg Med; 2002; 30(5):370-5. PubMed ID: 12116330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effectiveness of photodynamic therapy by using a hydrophilic photosensitizer ATX-S10(Na) against experimental choroidal neovascularization in rats.
    Kanai M; Obana A; Gohto Y; Nagata S; Miki T; Kaneda K; Nakajima S
    Lasers Surg Med; 2000; 26(1):48-57. PubMed ID: 10637003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-L-aspartyl chlorin e6.
    Mori K; Yoneya S; Anzail K; Kabasawa S; Sodeyama T; Peyman GA; Moshfeghi DM
    Retina; 2001; 21(5):499-508. PubMed ID: 11642380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.
    Husain D; Kramer M; Kenny AG; Michaud N; Flotte TJ; Gragoudas ES; Miller JW
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2322-31. PubMed ID: 10476799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes.
    Berdugo M; Bejjani RA; Valamanesh F; Savoldelli M; Jeanny JC; Blanc D; Ficheux H; Scherz A; Salomon Y; BenEzra D; Behar-Cohen F
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1633-44. PubMed ID: 18385085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.
    Schmidt-Erfurth U; Miller JW; Sickenberg M; Laqua H; Barbazetto I; Gragoudas ES; Zografos L; Piguet B; Pournaras CJ; Donati G; Lane AM; Birngruber R; van den Berg H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
    Arch Ophthalmol; 1999 Sep; 117(9):1177-87. PubMed ID: 10496389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence of early vascular events after photodynamic therapy.
    Michels S; Schmidt-Erfurth U
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):2147-54. PubMed ID: 12714655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.
    Miller JW; Schmidt-Erfurth U; Sickenberg M; Pournaras CJ; Laqua H; Barbazetto I; Zografos L; Piguet B; Donati G; Lane AM; Birngruber R; van den Berg H; Strong A; Manjuris U; Gray T; Fsadni M; Bressler NM; Gragoudas ES
    Arch Ophthalmol; 1999 Sep; 117(9):1161-73. PubMed ID: 10496388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic observation of selective accumulation of a photosensitizer and its photodynamic effects in rat experimental choroidal neovascularization.
    Hikichi T; Mori F; Nakajima S; Takamiya TA; Takeda M; Sasaki M; Horikawa Y; Yoshida A
    Retina; 2001; 21(2):126-31. PubMed ID: 11321138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of the phototoxicity of two chrolin type photosensitizers, ATX-S10(Na) and verteporfin, on vascular endothelial and retinal pigment epithelial cells.
    Huang Y; Obana A; Gohto Y; Nakajima S
    Lasers Surg Med; 2004; 34(3):216-26. PubMed ID: 15022248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
    Renno RZ; Terada Y; Haddadin MJ; Michaud NA; Gragoudas ES; Miller JW
    Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys.
    Kramer M; Miller JW; Michaud N; Moulton RS; Hasan T; Flotte TJ; Gragoudas ES
    Ophthalmology; 1996 Mar; 103(3):427-38. PubMed ID: 8600419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey.
    Husain D; Kim I; Gauthier D; Lane AM; Tsilimbaris MK; Ezra E; Connolly EJ; Michaud N; Gragoudas ES; O'Neill CA; Beyer JC; Miller JW
    Arch Ophthalmol; 2005 Apr; 123(4):509-16. PubMed ID: 15824225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anastomotic vessels remain viable after photodynamic therapy in primate models of choroidal neovascularization.
    Criswell MH; Ciulla TA; Lowseth LA; Small W; Danis RP; Carson DL
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2168-74. PubMed ID: 15914638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization.
    Zacks DN; Ezra E; Terada Y; Michaud N; Connolly E; Gragoudas ES; Miller JW
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2384-91. PubMed ID: 12091441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy of experimental choroidal neovascularization in the mouse.
    Odergren A; Ming Y; Kvanta A
    Curr Eye Res; 2006 Sep; 31(9):765-74. PubMed ID: 16966149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.